Tandem t:slim X2 User Manual page 303

Table 3. Amount of CGM Use Over the 21-Day Period by Treatment Arm (N=102)
Percentage of Time
Using the CGM a
≥ 90%
80 to < 90%
70 to < 80%
60 to < 70%
50 to <60%
< 50%
a. Denominator is the total possible time within the 21-day post-randomization study period. CGM use includes warm-up time.
Customer Technical Support: (877) 801-6901
Chapter 33 – Basal-IQ Technology Clinical Study Overview
Study Arm (Basal-IQ Enabled)
# participants % of population
75
21
3
0
1
2
# participants
74% 74
21% 20
3% 3
0% 2
< 1% 1
2% 2
Control Arm (SAP)
% of population
73%
20%
3%
2%
1%
2%
301